Benzimidazole derivatives

Details Benzimidazole derivatives Benzimidazole derivatives

2006-08-30

2009-12-22

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Four or more ring nitrogens in the bicyclo ring system

C514S234500

Reexamination Certificate

active

07635774

ABSTRACT:
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of inflammatory and immune-related conditions or disorders. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, immune response regulation and cell proliferation. The subject compounds are 2-amino-imidazole derivatives.

REFERENCES:
patent: 2928833 (1960-03-01), Leake et al.
patent: 3880874 (1975-04-01), Beard
patent: 3907700 (1975-09-01), Grier
patent: 3995050 (1976-11-01), Amselem
patent: 4002623 (1977-01-01), Kadin
patent: 4011236 (1977-03-01), Grier
patent: 4088768 (1978-05-01), Paget et al.
patent: 4492708 (1985-01-01), Spitzer
patent: 4835161 (1989-05-01), Janssens et al.
patent: 4874864 (1989-10-01), Schnur et al.
patent: 5654397 (1997-08-01), Cao et al.
patent: 5683999 (1997-11-01), Jadhav et al.
patent: 2 384 757 (1978-10-01), None
patent: 63159861 (1988-07-01), None
patent: 3-31264 (1991-02-01), None
patent: 11302177 (1999-11-01), None
patent: 2001-199968 (2001-07-01), None
patent: WO 93/23409 (1993-11-01), None
patent: WO 94/18212 (1994-08-01), None
patent: WO 97/25316 (1997-07-01), None
patent: WO 99/23091 (1999-05-01), None
patent: WO 00/01676 (2000-01-01), None
patent: WO 00/20358 (2000-04-01), None
patent: WO 00/27819 (2000-05-01), None
patent: WO 00/75310 (2000-12-01), None
patent: WO 00/51641 (2001-07-01), None
Auron, P., “The Interluekin 1 Receptor: Ligand Interactions and Signal Transduction,” Cytokine & Growth Fac. Rev., 1998, vol. 9, No. 3/4, pp. 221-237, GB.
Buscemi et al., “Heterocyclic Photoarrangements. Photochemical Behaviour of Some 3,5-Disubstituted 1,2,4-Oxadiazoles in Methanol at 254 nm,” J. of Heterocyclic Chem., 1988, vol. 25, No. 3, pp. 931-935, US.
Cao et al., “IRAK: A Kinase Associated with the Interleukin-1 Receptor,” Science, Feb. 23, 1996, vol. 271, pp. 1128-1131, US.
Cao et al., “TRAF is a Signal Transducer for Interleukin-1,” Nature, Oct. 3, 1996, vol. 383, pp. 443-446, US.
Dinarello, C., “Interleukin-1,” Cytokine & Growth Fac. Rev., 1997, vol. 8, No. 4, pp. 253-265, GB.
Heyer, D., “NPY5 Antagonists for Obesity,” Aug. 6, 2001, MedChem Gordon Research Conference 2001, Power Point Presentation Slides.
Kanakaraj et al., “Defective Interleukin (IL)-18-mediated Natural Killer and T Helper Cell Type 1 Responses in IL-1 Receptor-associated Kinase (IRAK)-deficient Mice,” J. Exp. Apr. 5, 1999, vol. 189, No. 7, pp. 1129-1138, The Rockefeller Univ. Press, US.
Moffett et al., “Antiulcer Agents. P-Aminobenzamido Aromatic Compounds,” J. of Medicinal Chem., 1971, vol. 14, No. 10, pp. 963-968, US.
Muzio et al., “IRAK (Pelle) Family Member IRAK-2 and MyD88 as Proximal Mediators of IL-1 Signaling,” Science, Nov. 28, 1997, vol. 278, pp. 1612-1615, US.
O'Neill et al., “Signal Transduction Pathways Activated by the IL-1 Receptor Family: Ancient Signaling Machinery in Mammals, Insects and Plants,” J. of Leukocyte Bio., Jun. 1998, vol. 63, pp. 650-657, US.
O'Neill, L., “The Toll/Interleukin-1 Receptor Domain: a Molecular Switch for Inflammation and Hose Defence,” Biochemical Society Transactions, 2000, vol. 28, Pt. 5, pp. 557-563, Trinity College, Ireland.
Wesche et al., “IRAK-M is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family,” J. of Bio. Chem., Jul. 2, 1999, vol. 274, No. 27, pp. 19403-19410, US.
Yang et al., “Signaling Events Induced by Lipopolysaccharide-activated Toll-like Receptor-2,” J. of Immunology, 1999, vol. 163, pp. 639-643, US.
Japanese Patent Office, Notification of Reasons for Refusal in Japanese Patent Application No. 2003-533934, Apr. 21, 2009.

Affiliated with

Also associated with

Rating

Benzimidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4066681